| Primary |
| Hiv Infection |
71.1% |
| Hypertension |
10.5% |
| Immunosuppressant Drug Therapy |
7.9% |
| Sinus Congestion |
7.9% |
| Drug Withdrawal Maintenance Therapy |
2.6% |
|
| Convulsion |
20.0% |
| Hypertensive Crisis |
20.0% |
| Urine Output Decreased |
20.0% |
| Aphasia |
10.0% |
| Status Epilepticus |
10.0% |
| Vomiting |
10.0% |
| Xeroderma Pigmentosum |
10.0% |
|
| Secondary |
| Hiv Infection |
58.1% |
| Drug Use For Unknown Indication |
18.4% |
| Product Used For Unknown Indication |
9.1% |
| Prophylaxis |
3.6% |
| Insomnia |
1.9% |
| Pain |
1.4% |
| Haemorrhoids |
0.8% |
| Candidiasis |
0.7% |
| Depression |
0.7% |
| Diarrhoea |
0.6% |
| Syphilis |
0.6% |
| Castleman's Disease |
0.6% |
| Kaposi's Sarcoma |
0.6% |
| Osteoporosis Prophylaxis |
0.6% |
| Factor Viii Deficiency |
0.5% |
| Lower Gastrointestinal Haemorrhage |
0.5% |
| Hiv Test Positive |
0.4% |
| Hyperlipidaemia |
0.4% |
| Anxiety |
0.3% |
| Cachexia |
0.3% |
|
| Weight Decreased |
24.3% |
| Rash Maculo-papular |
10.3% |
| Renal Failure Acute |
6.5% |
| Blood Bilirubin Increased |
5.6% |
| Hepatic Failure |
5.6% |
| Sinusitis |
5.6% |
| Hepatic Enzyme Increased |
4.7% |
| Pancreatitis |
4.7% |
| Blood Creatine Phosphokinase Increased |
3.7% |
| Deep Vein Thrombosis |
3.7% |
| Hepatitis |
3.7% |
| Pancreatitis Acute |
3.7% |
| Sepsis |
3.7% |
| Immune Reconstitution Syndrome |
2.8% |
| Blood Lactate Dehydrogenase Increased |
1.9% |
| Breast Cancer |
1.9% |
| Death |
1.9% |
| Diarrhoea |
1.9% |
| Hepatitis Cholestatic |
1.9% |
| Lymphoma |
1.9% |
|
| Concomitant |
| Hiv Infection |
77.8% |
| Prophylaxis |
2.7% |
| Antifungal Prophylaxis |
2.4% |
| Diarrhoea |
2.1% |
| Antacid Therapy |
1.8% |
| Drug Use For Unknown Indication |
1.8% |
| Nausea |
1.2% |
| Abdominal Distension |
1.0% |
| Hypertension |
1.0% |
| Factor Viii Deficiency |
0.9% |
| Hiv Test Positive |
0.9% |
| Weight Increased |
0.9% |
| Cytomegalovirus Infection |
0.8% |
| Depression |
0.8% |
| Herpes Simplex |
0.8% |
| Cachexia |
0.7% |
| Cough |
0.7% |
| Pain |
0.7% |
| Analgesia |
0.5% |
| Diuretic Therapy |
0.5% |
|
| Pulmonary Embolism |
13.0% |
| Pancreatitis |
10.9% |
| Systemic Candida |
10.9% |
| Vomiting |
8.7% |
| Renal Failure Acute |
5.4% |
| Cardiomyopathy |
4.3% |
| Hepatitis |
4.3% |
| Hepatitis Cholestatic |
4.3% |
| Mycobacterium Avium Complex Infection |
4.3% |
| Pancreatitis Chronic |
4.3% |
| Pancytopenia |
4.3% |
| Respiratory Arrest |
4.3% |
| Bradycardia |
3.3% |
| Pancreatitis Acute |
3.3% |
| Sinusitis |
3.3% |
| Aspartate Aminotransferase Increased |
2.2% |
| Drug Prescribing Error |
2.2% |
| Left Ventricular Failure |
2.2% |
| Liver Disorder |
2.2% |
| Malaise |
2.2% |
|
| Interacting |
| Hypertension |
54.5% |
| Hiv Infection |
45.5% |
|
| Hypertensive Crisis |
80.0% |
| Neuropathy Peripheral |
20.0% |
|
